radiolabeled leukotrine B4 antagonist (University of Nijmegen/BMS)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameradiolabeled leukotrine B4 antagonist (University of Nijmegen/BMS)
Drug Alias NameLTB4 antagonist imaging agent (University of Nijmegen/BMS)99mTc-(BMS-57868-88)99mTc-MB-88111In-DPC-11870indium-111-DPC-11870 +[8] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules
Mechanisms of ActionLeukotriene B4 receptor antagonists
TargetsLeukotriene B4 receptor
Therapy Area/IndicationsInflammationCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRadboud University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRadboud UniversityLantheus Holdings Inc
Active IndicationsN/A
Inactive IndicationsInflammationCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A